NECTIN4 and ovarian carcinoma: Our study showed that the treatment of ovarian cancer cells with the Nectin-4 peptide N4-P10 inhibited cell aggregation and increased the cytotoxicity of cisplatin, and has the potential for development into a novel treatment that will increase the effectiveness of IP chemotherapy and prevent tumor recurrence in ovarian cancer patients.